Target intelligence / Profile preview

Streptococcus uberis whole-cell antigens (S. uberis antigens)

Target
S. uberis antigens
Molecular classification
Bacterial antigen, Immunogen, Other
01

Overview

Streptococcus uberis is a Gram-positive, environmental pathogen that serves as a leading cause of clinical and subclinical mastitis in dairy cattle worldwide (Leigh, 1999). The whole-cell antigens of S. uberis encompass the entire suite of molecular components—including surface proteins like adhesion proteins (Sua), capsule polysaccharides, and lipoteichoic acids—presented by the inactivated bacterium (Ward et al., 2009). These antigens are primarily targeted in the development of bacterin vaccines, which aim to elicit a robust humoral immune response to prevent bacterial colonization and invasion of the mammary gland (Collado et al., 2018). Upon administration, the host immune system recognizes these diverse epitopes, stimulating the production of antibodies that facilitate opsonization and subsequent clearance by neutrophils (Schukken et al., 2011). This immunological approach is intended to reduce the severity of clinical mastitis and lower the somatic cell count in milk, thereby improving animal welfare and dairy productivity. However, the significant genetic diversity among S. uberis strains remains a major hurdle, as whole-cell antigens from one strain may not provide universal protection against all environmental variants (Leigh, 1999).

Other names
Streptococcus uberis bacterinS. uberis inactivated whole cellsStreptococcus uberis surface antigens
02

Mechanism of action

Induction of active immunity through the presentation of multiple bacterial epitopes to the host immune system, leading to the production of specific antibodies (IgG1 and IgG2) that enhance opsonization and phagocytic killing of the bacteria by mammary gland neutrophils (Collado et al., 2018; Schukken et al., 2011).

03

Biological functions

Immune responsePathogenesisBacterial adhesionOther
04

Disease associations

InfectionBovine mastitisOther
05

Safety considerations

Injection site swellingLimited cross-protection between heterologous strainsTransient increase in body temperature (Collado et al., 2018)Potential for hypersensitivity reactions
06

Interacting drugs

Ubac
07

Biomarkers

Anti-Streptococcus uberis IgG titersSomatic cell count (SCC)Milk yieldMilk amyloid A (MAA)

Beyond the preview

Go deeper on Streptococcus uberis whole-cell antigens (S. uberis antigens).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Streptococcus uberis whole-cell antigens (S. uberis antigens).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call